Raising NAD in Heart Failure: Time to Translate?

Circulation. 2018 May 22;137(21):2274-2277. doi: 10.1161/CIRCULATIONAHA.117.032626.

Authors

Matthew A Walker¹, Rong Tian²

Affiliations

¹ Mitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle.
² Mitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle. rongtian@u.washington.edu.

No abstract available

Keywords: Editorials; NAD; heart failure; nicotinamide riboside.

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Animals
Cardiomyopathy, Dilated*
Heart Failure*
Mice
NAD
Niacinamide / analogs & derivatives
Pyridinium Compounds

Substances

Pyridinium Compounds
nicotinamide-beta-riboside
NAD
Niacinamide

Grants and funding